EmbryoTrans Biotech ApS: Financial statements 2018
CVR: 36701676
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
EmbryoTrans Biotech ApS (CVR 36701676) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,135,620 and a net result of DKK -17,779 compared with DKK 172,405 the year before. That is a decrease of 38.2% compared with the year before. Equity in the 2018 report amounted to DKK 259,622. The solvency ratio was 34.8%.
- Gross Profit
- DKK 1,135,620
- Profit/Loss
- DKK -17,779
- Equity
- DKK 259,622
- Total Assets
- DKK 745,402
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1.1 mio. | -18 t. | 260 t. | - |
| 2017 | - | 1.8 mio. | 172 t. | 377 t. | - |
| 2016 | - | 1.8 mio. | 132 t. | 455 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
EmbryoTrans Biotech ApS has published its annual report for 2017. Gross profit came to DKK 1,838,431, and the net result was DKK 172,405.
About EmbryoTrans Biotech ApS
EmbryoTrans Biotech ApS was a Danish company of the type Anpartsselskab based in Hundested, founded in 2015. The company has been dissolved on 23 February 2022. The company was registered under the industry Detailhandel med medicinske og ortopædiske artikler. The company has 4 employees (2018). In 2020, the company reported a gross profit of DKK 520,019 and a net result of DKK -10,407 compared with DKK 23,111 the year before. Equity in the 2020 report amounted to DKK 242,326.